Liposome formulations of o-carborane for the boron neutron capture therapy of cancer

Temidayo Olusanya, Gianpiero Calabrese, Dimitrios G. Fatouros, John Tsibouklis, James Smith

Research output: Contribution to journalArticlepeer-review

13 Downloads (Pure)


Based on the promise of liposomes as convenient vehicles for the transport of boronated agents for the boron neutron capture therapy (BCNT) of cancer, this paper reports a method for the formulation and characterisation of stable o-carborane-loaded liposomes (ca. 80 – 100 nm) of dipalmitoyl-phosphatidylcholine (DPPC) or 1,2-distearol-sn-glycerol-3-phosphocholine (DSPC). Preliminary pharmaceutical characterisation experiments have demonstrated the integrity of both DPPC and DSPC liposomal membranes in serum and in PBS and also indicate that these o-carborane-loaded liposomes are candidate carrier vehicles for further evaluation with a view to exploitation in BNCT.
Original languageEnglish
Pages (from-to)25-33
JournalBiophysical Chemistry
Early online date15 Feb 2019
Publication statusPublished - Apr 2019


  • liposomes
  • Cancer
  • BNCT
  • Nanoparticles


Dive into the research topics of 'Liposome formulations of <i>o</i>-carborane for the boron neutron capture therapy of cancer'. Together they form a unique fingerprint.

Cite this